COSCIENS Biopharma Inc. (CSCI) — Cash Flow Quality Index
COSCIENS Biopharma Inc. (CSCI) has a Cash Flow Quality Index of 1.83x as of September 2022. Operating cash flow of $1.06 Million exceeds net income of $576.57K, indicating high earnings quality where cash backs reported profits. Also explore COSCIENS Biopharma Inc. asset portfolio for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
COSCIENS Biopharma Inc. Cash Flow Quality Index (2002–2022)
Historical Cash Flow Quality Index for COSCIENS Biopharma Inc. across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check COSCIENS Biopharma Inc. tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for COSCIENS Biopharma Inc. (2002–2022)
Year-by-year earnings quality comparison for COSCIENS Biopharma Inc.. For live market cap and the full company financial profile, see CSCI market cap overview.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 1.52x | $5.23 Million | $3.45 Million | ▲ +45.4% |
| 2021 | 1.04x | $2.75 Million | $2.64 Million | ▼ -56.5% |
| 2020 | 2.40x | $3.49 Million | $1.46 Million | ▲ +77.8% |
| 2016 | 1.35x | $3.63 Million | $2.69 Million | ▲ +66.8% |
| 2015 | 0.81x | $2.87 Million | $3.55 Million | ▼ -39.6% |
| 2014 | 1.34x | $1.84 Million | $1.37 Million | ▼ -51.9% |
| 2013 | 2.79x | $460.21K | $165.11K | ▲ +99.2% |
| 2011 | 1.40x | $791.62K | $565.69K | ▲ +35.3% |
| 2010 | 1.03x | $479.50K | $463.65K | ▲ +547.8% |
| 2003 | 0.16x | $54.42K | $340.88K | ▲ +120.3% |
| 2002 | -0.79x | $-57.75K | $73.54K | — |